The mechanism by which aspirin improves the prognosis of ovarian cancer is usually thought to be related to COX inhibition, with low-dose aspirin primarily inhibiting COX1 and higher doses inhibiting COX2 activity. The gene discussed is PTGS2; the disease is ovarian cancer.